Paper2178792
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
Foster BJ and 5 others. Cancer Chemother Pharmacol, 1990. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP. Papers, record 2178792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2178792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cisplatin | Major topic |
| Organoplatinum Compounds | Major topic |
| Animals | |
| Carboplatin | |
| Chemical Phenomena | |
| Chemistry | |
| Drug Design | |
| Drug Evaluation | |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Leukemia L1210 | |
| Male | |
| Mice | |
| Neoplasms, Experimental | |
| Rats | |
| Rats, Inbred F344 |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 761445 | Kinetics of cis-dichlorodiammineplatinum. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/761445 | PubMed |
| 2 | 4586953 | Cis-diamminedichloroplatinum (NSC-119875): a phase I study. | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4586953 | PubMed |
| 3 | 5479434 | Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro. | Int J Cancer | 1970 | https://conductscience.org/library/papers/5479434 | PubMed |
| 4 | 387222 | Mode of DNA binding of cis-platinum(II) antitumor drugs: a base sequence-dependent mechanism is proposed. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/387222 | PubMed |
| 5 | 7194166 | Clinical kinetics on intact cisplatin and some related species. | Clin Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7194166 | PubMed |
| 6 | 6392147 | A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6392147 | PubMed |
| 7 | 4689325 | Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites. | J Am Chem Soc | 1973 | https://conductscience.org/library/papers/4689325 | PubMed |
| 8 | 498150 | Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/498150 | PubMed |
| 9 | 1174534 | X-ray photoelectron spectroscopy of DNA-Pt complexes. Evidence of O6 (Gua)-N7 (Gua) chelation of DNA with cis- dichlorodiamine platinum(II). | Biochim Biophys Acta | 1975 | https://conductscience.org/library/papers/1174534 | PubMed |
| 10 | 498145 | Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/498145 | PubMed |
| 11 | 7191777 | Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo. | Cancer Res | 1980 | https://conductscience.org/library/papers/7191777 | PubMed |
| 12 | 6272211 | Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples. | Nucleic Acids Res | 1981 | https://conductscience.org/library/papers/6272211 | PubMed |
| 13 | 4551181 | Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds. | Nature | 1972 | https://conductscience.org/library/papers/4551181 | PubMed |
| 14 | 7199380 | Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. | Cancer Res | 1982 | https://conductscience.org/library/papers/7199380 | PubMed |
| 15 | 6367971 | Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. | Cancer Res | 1984 | https://conductscience.org/library/papers/6367971 | PubMed |
| 16 | 2674333 | A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2674333 | PubMed |
| 17 | 6883623 | Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6883623 | PubMed |
| 18 | 3510700 | Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion. | Cancer | 1986 | https://conductscience.org/library/papers/3510700 | PubMed |
| 19 | 291481 | Platinum analogs of clinical interest. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/291481 | PubMed |
| 20 | 6761010 | Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6761010 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8512813 | A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8512813 | PubMed |
| 8453687 | Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8453687 | PubMed |
| 8258189 | Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8258189 | PubMed |
| 7981487 | New platinum agents. A comparison in ovarian cancer. | Drugs Aging | 1994 | https://conductscience.org/library/papers/7981487 | PubMed |
| 1906857 | Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1906857 | PubMed |
| 1583000 | Serum-free media for murine erythroleukemia cells still not as good as serum-supplemented media. | In Vitro Cell Dev Biol | 1992 | https://conductscience.org/library/papers/1583000 | PubMed |
| 1503895 | Modulation of cis-diamminedichloroplatinum(II) resistance: a review. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1503895 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2178792
GET https://conductscience.org/api/papers/v1/2178792/references?page=2